• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-HT3 受体:新型抗抑郁药物的靶标。

5HT3 receptors: Target for new antidepressant drugs.

机构信息

Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Rajasthan 333031, India.

出版信息

Neurosci Biobehav Rev. 2016 May;64:311-25. doi: 10.1016/j.neubiorev.2016.03.001. Epub 2016 Mar 11.

DOI:10.1016/j.neubiorev.2016.03.001
PMID:26976353
Abstract

5HT3 receptors (5HT3Rs) have long been identified as a potential target for antidepressants. Several studies have reported that antagonism of 5HT3Rs produces antidepressant-like effects. However, the exact role of 5HT3Rs and the mode of antidepressant action of 5HT3R antagonists still remain a mystery. Here, we provide a comprehensive overview of 5HT3Rs: (a) regional and subcellular distribution of 5HT3Rs in discrete brain regions, (b) preclinical and clinical evidence supporting the antidepressant effect of 5HT3R antagonists, and (c) neurochemical, biological and neurocellular signaling pathways associated with the antidepressant action of 5HT3R antagonists. 5HT3Rs located on the serotonergic and other neurotransmitter interneuronal projections control their release and affect mood and emotional behavior; however, new evidence suggests that apart from modulating the neurotransmitter functions, 5HT3R antagonists have protective effects in the pathogenic events including hypothalamic-pituitary-adrenal-axis hyperactivity, brain oxidative stress and impaired neuronal plasticity, pointing to hereby unknown and novel mechanisms of their antidepressant action. Nonetheless, further investigations are warranted to establish the exact role of 5HT3Rs in depression and antidepressant action of 5HT3R antagonists.

摘要

5-HT3 受体(5HT3Rs)长期以来一直被认为是抗抑郁药的潜在靶点。多项研究报告称,拮抗 5HT3Rs 可产生抗抑郁样作用。然而,5HT3Rs 的确切作用以及 5HT3R 拮抗剂的抗抑郁作用模式仍然是一个谜。在这里,我们提供了一个全面的 5HT3Rs 概述:(a)5HT3Rs 在离散脑区中的区域和亚细胞分布,(b)支持 5HT3R 拮抗剂抗抑郁作用的临床前和临床证据,以及(c)与 5HT3R 拮抗剂抗抑郁作用相关的神经化学、生物学和神经细胞信号通路。位于 5-HT 能和其他神经递质中间神经元投射上的 5HT3Rs 控制它们的释放,影响情绪和情绪行为;然而,新的证据表明,除了调节神经递质功能外,5HT3R 拮抗剂在包括下丘脑-垂体-肾上腺轴活性亢进、脑氧化应激和神经元可塑性受损在内的致病事件中具有保护作用,这表明它们具有未知的和新的抗抑郁作用机制。尽管如此,仍需要进一步的研究来确定 5HT3Rs 在抑郁症中的确切作用以及 5HT3R 拮抗剂的抗抑郁作用。

相似文献

1
5HT3 receptors: Target for new antidepressant drugs.5-HT3 受体:新型抗抑郁药物的靶标。
Neurosci Biobehav Rev. 2016 May;64:311-25. doi: 10.1016/j.neubiorev.2016.03.001. Epub 2016 Mar 11.
2
A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system.一种新型5-羟色胺3(5HT3)拮抗剂4i(N-(3-氯-2-甲基苯基)喹喔啉-2-甲酰胺)可预防小鼠糖尿病诱导的抑郁表型:对血清素能系统的调节
Behav Brain Res. 2016 Jan 15;297:41-50. doi: 10.1016/j.bbr.2015.10.007. Epub 2015 Oct 22.
3
Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.新型5-羟色胺3(5-HT3)受体拮抗剂6z在急性和慢性小鼠抑郁模型中的抗抑郁样作用
Acta Pharmacol Sin. 2014 Dec;35(12):1493-503. doi: 10.1038/aps.2014.89. Epub 2014 Nov 24.
4
5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.5-羟色胺3受体拮抗剂(昂丹司琼)可逆转慢性不可预测应激诱发的小鼠抑郁行为:对下丘脑-垂体-肾上腺皮质及脑血清素能系统的调节
Pharmacol Biochem Behav. 2014 Sep;124:129-36. doi: 10.1016/j.pbb.2014.05.024. Epub 2014 Jun 6.
5
Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice.新型5-羟色胺3受体拮抗剂4i对皮质酮诱导的小鼠抑郁样行为和氧化应激的影响。
Steroids. 2015 Apr;96:95-102. doi: 10.1016/j.steroids.2015.01.021. Epub 2015 Feb 7.
6
Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.昂丹司琼,一种 5HT3 受体拮抗剂,可逆转链脲佐菌素诱导的糖尿病小鼠的抑郁和焦虑样行为:可能涉及 5-羟色胺能系统。
Eur J Pharmacol. 2014 Dec 5;744:59-66. doi: 10.1016/j.ejphar.2014.09.041. Epub 2014 Oct 2.
7
Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention.抑郁症与肥胖共病的机制:一种新型治疗干预的 5-羟色胺能 3 型受体拮抗剂方法。
Asian J Psychiatr. 2015 Oct;17:3-9. doi: 10.1016/j.ajp.2015.07.007. Epub 2015 Jul 18.
8
2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.2-氨基-6-氯-3,4-二氢喹唑啉:一种具有抗抑郁作用的新型 5-HT3 受体拮抗剂。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5945-8. doi: 10.1016/j.bmcl.2013.08.072. Epub 2013 Aug 24.
9
QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.QCM-4,一种新型 5-HT3 拮抗剂,可减轻慢性不可预知轻度应激抑郁模型中瑞士白化小鼠的行为和生化改变。
J Pharm Pharmacol. 2014 Jan;66(1):122-32. doi: 10.1111/jphp.12163. Epub 2013 Nov 4.
10
QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.QCM-4,一种5-羟色胺受体拮抗剂,可改善肥胖小鼠抑郁和焦虑样行为中的血浆下丘脑-垂体-肾上腺(HPA)轴功能亢进、瘦素抵抗及脑氧化应激。
Biochem Biophys Res Commun. 2015 Jan 2;456(1):74-9. doi: 10.1016/j.bbrc.2014.11.036. Epub 2014 Nov 21.

引用本文的文献

1
Serotonin (5-Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities.血清素(5-羟色胺):代谢、信号传导、生物学功能、疾病及新兴治疗机遇
MedComm (2020). 2025 Sep 9;6(9):e70383. doi: 10.1002/mco2.70383. eCollection 2025 Sep.
2
Serotonin Receptors in Areas of the Emotion Regulation Network in Human and Rat Brains-A Comparative Autoradiographic Study.人类和大鼠大脑情绪调节网络区域中的血清素受体——一项比较放射自显影研究
J Comp Neurol. 2025 Jul;533(7):e70068. doi: 10.1002/cne.70068.
3
Pharmaceutical Studies on Piperazine-based Compounds Targeting Serotonin Receptors and Serotonin Reuptake Transporters.
针对5-羟色胺受体和5-羟色胺再摄取转运体的哌嗪类化合物的药学研究
Mini Rev Med Chem. 2025;25(1):58-75. doi: 10.2174/0113895575319878240612070850.
4
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels.《药理学简明指南 2023/24 年版》:离子通道。
Br J Pharmacol. 2023 Oct;180 Suppl 2(Suppl 2):S145-S222. doi: 10.1111/bph.16178.
5
Derivatives of 3, 4, 5-Trimethoxycinnamic Acid Ameliorate Stress-Induced Anxiety in Mice and Rats.3,4,5-三甲氧基肉桂酸衍生物可改善小鼠和大鼠的应激诱导焦虑。
Mol Neurobiol. 2023 May;60(5):2737-2748. doi: 10.1007/s12035-023-03240-y. Epub 2023 Jan 30.
6
Heterotopic 4T1 breast cancer transplantation induces hippocampal inflammation and depressive-like behaviors in mice.异位4T1乳腺癌移植可诱导小鼠海马炎症和抑郁样行为。
Metab Brain Dis. 2022 Dec;37(8):2955-2963. doi: 10.1007/s11011-022-01058-6. Epub 2022 Aug 10.
7
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update.伏硫西汀——慢性神经性疼痛治疗的新前沿:综述与更新
Ther Adv Psychopharmacol. 2021 Sep 3;11:20451253211034320. doi: 10.1177/20451253211034320. eCollection 2021.
8
5-HT Receptors and the Development of New Antidepressants.5-羟色胺受体与新型抗抑郁药的研发。
Int J Mol Sci. 2021 Aug 20;22(16):9015. doi: 10.3390/ijms22169015.
9
The Roles of Serotonin in Neuropsychiatric Disorders.血清素在神经精神疾病中的作用。
Cell Mol Neurobiol. 2022 Aug;42(6):1671-1692. doi: 10.1007/s10571-021-01064-9. Epub 2021 Mar 2.
10
Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor.文拉法辛、鲁拉西酮和依他普仑对与 5-HT7 受体相关的丘脑皮质谷氨酸能传递的亚慢性作用。
Int J Mol Sci. 2021 Jan 29;22(3):1351. doi: 10.3390/ijms22031351.